Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Oxford, Oxon, OX3 7LJ, United Kingdom
NCT Number: NCT00310700
Kinetics of B cell response in infants Menjugate vaccination
Looking for future studies?
Notify Me8 week–11 week
All sexes
Interventional
Phase 4
Oxford, Oxon, OX3 7LJ, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Novartis
Industry
A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the First and the Third Immunization With Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Infants at 2, 3 and 4 Months of Age
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00316654
Prevention of Meningococcal Infection
Olsztyn, Lubartów, Kielce, Kraków, Bydgoszcz, Poland
View Trial DetailsNCT00310687
Prevention of Meningococcal Infection
Headington, Oxfordshire, United Kingdom
View Trial DetailsNCT00310713
Prevention of Meningococcal Infection
Headington, Oxford, United Kingdom
View Trial DetailsNCT00311415
Prevention of Meningococcal Infection
Mainz, Kehl, Neumünster, Ettenheim, Germany
View Trial Details